TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10381294

Group type: EXPERIMENTAL
Intervention: Spontaneous platelet aggregation
Number of subjects: 2873

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 2873

Group type: EXPERIMENTAL
Intervention: Lower HDL-levels
Number of subjects: 2873

Group type: EXPERIMENTAL
Intervention: Elevated diastolic blood pressure
Number of subjects: 2873

Group type: EXPERIMENTAL
Intervention: Slightly elevated blood glucose
Number of subjects: 2873

Group type: EXPERIMENTAL
Intervention: Higher fibrinogen levels
Number of subjects: 2873

Group type: EXPERIMENTAL
Intervention: None of the other hemostatic parameters
Number of subjects: 2873
Study: 8885615

Group type: EXPERIMENTAL
Intervention: Canvas shoes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plastazote/moulded shoes
Number of subjects: 0
Study: 2064880

Group type: EXPERIMENTAL
Intervention: Diamorphine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 12
Study: 500834

Group type: EXPERIMENTAL
Intervention: Calcium ingestion (0.0, 0.5, 1.5, and 3.0 g of elemental calcium as gluconate)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (ingestion of distilled water)
Number of subjects: 10
Study: 31538444

Group type: EXPERIMENTAL
Intervention: Decontaminant material (sulfonic/sulphuric acid solution, HybenX, EPIEN Medical)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sodium hypochlorite 5% (control group)
Number of subjects: 60
Study: 28005225

Group type: EXPERIMENTAL
Intervention: BAY 81-8973 (50 IU/kg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: rAHF-PFM (50 IU/kg)
Number of subjects: 18
Study: 25462664

Group type: EXPERIMENTAL
Intervention: Quit forever goal
Number of subjects: 808

Group type: EXPERIMENTAL
Intervention: Abstinence goal
Number of subjects: 808

Group type: EXPERIMENTAL
Intervention: Lower educational level
Number of subjects: 808
Study: 23595929

Group type: EXPERIMENTAL
Intervention: Templated 4+1 model of residency
Number of subjects: 0
Study: 21619622

Group type: EXPERIMENTAL
Intervention: Full-serve version of SHARE
Number of subjects: 120

Group type: COMPARATOR
Intervention: Self-serve version of SHARE
Number of subjects: 120
Study: 19266588

Group type: EXPERIMENTAL
Intervention: Direct Magnitude Estimation (DME) scaling method
Number of subjects: 27

Group type: COMPARATOR
Intervention: Equal Appearing Interval (EAI) scaling method
Number of subjects: 27
Study: 17062601

Group type: EXPERIMENTAL
Intervention: TPB questionnaire plus leaflet-like intervention
Number of subjects: 573

Group type: COMPARATOR
Intervention: TPB questionnaire only
Number of subjects: 573
Study: 16896425

Group type: EXPERIMENTAL
Intervention: OxyMask
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Modified OxyMask
Number of subjects: 26

Group type: COMPARATOR
Intervention: Venturi mask
Number of subjects: 26
Study: 14657773

Group type: EXPERIMENTAL
Intervention: Laryngeal mask
Number of subjects: 46

Group type: COMPARATOR
Intervention: Face mask
Number of subjects: 46
Study: 9929017

Group type: EXPERIMENTAL
Intervention: leflunomide (100 mg daily on days 1-3, then 20 mg daily)
Number of subjects: 358

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: sulphasalazine (0.5 g daily, titrated to 2.0 g daily at week 4)
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: leflunomide
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: sulphasalazine
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: leflunomide and sulphasalazine
Number of subjects: 358
Study: 7486098

Group type: EXPERIMENTAL
Intervention: Ropivacaine 1 mg/mL (0.1%)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Ropivacaine 2 mg/mL (0.2%)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Ropivacaine 3 mg/mL (0.3%)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Bupivacaine 2.5 mg/mL (0.25%)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (sodium chloride 0.9%)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Ropivacaine (various doses)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Bupivacaine (2.5 mg/mL)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Ropivacaine and Bupivacaine
Number of subjects: 37
Study: 2354484

Group type: EXPERIMENTAL
Intervention: Nitrendipine 20 mg once daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: Nicardipine 20 mg thrice daily
Number of subjects: 24
Study: 466753

Group type: EXPERIMENTAL
Intervention: Intravenous 20 micrograms NAB 365 (clenbuterol)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Intravenous 250 micrograms terbutaline
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 31855717

Group type: EXPERIMENTAL
Intervention: SDF Intervention positioning
Number of subjects: 34

Group type: COMPARATOR
Intervention: Vertical Control
Number of subjects: 34
Study: 29801515

Group type: EXPERIMENTAL
Intervention: DC vaccination as an add-on to the standard therapy
Number of subjects: 136

Group type: COMPARATOR
Intervention: Standard radio/temozolomide chemotherapy
Number of subjects: 136
Study: 27503851

Group type: EXPERIMENTAL
Intervention: High-sodium diet
Number of subjects: 71

Group type: COMPARATOR
Intervention: Low-sodium diet
Number of subjects: 71
Study: 23944875

Group type: EXPERIMENTAL
Intervention: MD-Logic artificial pancreas (closed-loop)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sensor-augmented pump therapy (control)
Number of subjects: 15
Study: 23009149

Group type: EXPERIMENTAL
Intervention: Exercise and nutrition (EN)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Problem solving therapy (PST)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Non-EN
Number of subjects: 117

Group type: COMPARATOR
Intervention: Non-PST
Number of subjects: 117
Study: 21077572

Group type: EXPERIMENTAL
Intervention: Citalopram (CIT) 20 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Imipramine (IMI) 75 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 18518892

Group type: EXPERIMENTAL
Intervention: Sitagliptin (50 mg once daily for moderate renal insufficiency; 25 mg once daily for severe renal insufficiency)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo followed by glipizide (2.5 or 5 mg/day, uptitrated to max 20 mg/day)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo/glipizide
Number of subjects: 91
Study: 16203961

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 36

Group type: COMPARATOR
Intervention: Clonidine
Number of subjects: 36
Study: 11828246

Group type: EXPERIMENTAL
Intervention: C (caffeine 4 mg/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: E (ephedrine 0.8 mg/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: C + E (caffeine 4 mg/kg + ephedrine 0.8 mg/kg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: P (placebo)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: E (ephedrine 0.8 mg/kg) and C + E
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: C + E
Number of subjects: 12
Study: 10072747

Group type: EXPERIMENTAL
Intervention: Nutrition intervention (2-year program including classes, mailed self-help materials, and personalized dietary feedback)
Number of subjects: 5042

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 5042
Study: 8547834

Group type: EXPERIMENTAL
Intervention: Daily supplementation of retinol (25,000 IU) for 5 years in SKICAP-AK trial
Number of subjects: 3519

Group type: EXPERIMENTAL
Intervention: Daily supplementation of retinol (25,000 IU) or 13‐cis‐retinoic acid (5 or 10 mg) for 3 years in SKICAP-S/B trial
Number of subjects: 3519
Study: 2310247

Group type: EXPERIMENTAL
Intervention: Nicardipine cardioplegia (0.25 mg/L)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Standard potassium cardioplegia
Number of subjects: 33
Study: 7003700

Group type: EXPERIMENTAL
Intervention: Radiotherapy plus chemotherapy (RT+CT)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Radiotherapy (TNI)
Number of subjects: 237
Study: 30602360

Group type: EXPERIMENTAL
Intervention: Postconditioning (4, 30 seconds PTCA inflations/deflations) + PCI (n=65)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Routine PCI (n=57)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Postconditioning
Number of subjects: 122

Group type: COMPARATOR
Intervention: Routine PCI
Number of subjects: 122
Study: 28109295

Group type: EXPERIMENTAL
Intervention: linagliptin 5 mg qd
Number of subjects: 42

Group type: COMPARATOR
Intervention: glimepiride 1-4 mg qd
Number of subjects: 42

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 42
Study: 25844905

Group type: EXPERIMENTAL
Intervention: Deliberative decision strategies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intuitive decision strategies
Number of subjects: 0
Study: 24064010

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 13608

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 13608

Group type: EXPERIMENTAL
Intervention: Overall (both treatments)
Number of subjects: 13608

Group type: EXPERIMENTAL
Intervention: Overall (sensitivity analysis excluding periprocedural acute-ST)
Number of subjects: 13608
Study: 20428935

Group type: EXPERIMENTAL
Intervention: $10 CVS gift card incentive
Number of subjects: 550

Group type: COMPARATOR
Intervention: 30‐min prepaid phone card
Number of subjects: 550
Study: 19592292

Group type: EXPERIMENTAL
Intervention: Low Dk (etafilcon A) soft contact lenses
Number of subjects: 20

Group type: COMPARATOR
Intervention: High Dk (lotrafilcon A) soft contact lenses
Number of subjects: 20
Study: 17449179

Group type: EXPERIMENTAL
Intervention: Sumatriptan
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 12
Study: 15118806

Group type: EXPERIMENTAL
Intervention: Lorazepam and alcohol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 11110572

Group type: EXPERIMENTAL
Intervention: HoLRP
Number of subjects: 120

Group type: COMPARATOR
Intervention: TURP
Number of subjects: 120
Study: 9332804

Group type: EXPERIMENTAL
Intervention: Professional tooth cleaning and oral health education program (test)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Standard preventive program (control)
Number of subjects: 404
Study: 8476960

Group type: EXPERIMENTAL
Intervention: Roxithromycin 300 mg once a day
Number of subjects: 211

Group type: COMPARATOR
Intervention: Doxycycline 200 mg day 1 and 100 mg day 2-10
Number of subjects: 211

Group type: COMPARATOR
Intervention: Doxycycline
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Roxithromycin
Number of subjects: 211
Study: 4023557

Group type: EXPERIMENTAL
Intervention: Praziquantel treatment
Number of subjects: 34
Study: 30683523

Group type: EXPERIMENTAL
Intervention: Intravenous TXA (15mg/kg)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Intra-articular TXA (2g)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 78
Study: 29716576

Group type: EXPERIMENTAL
Intervention: 7-week online mindfulness training
Number of subjects: 160

Group type: COMPARATOR
Intervention: Waitlisted control group
Number of subjects: 160
Study: 24800718

Group type: EXPERIMENTAL
Intervention: Noxious thermal stimulation (46°C‐47°C heat and 7°C‐8°C cold)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Innocuous thermal stimulation (40°C‐41°C heat and 20°C‐21°C cold)
Number of subjects: 16
Study: 23272199

Group type: EXPERIMENTAL
Intervention: Leadership training program (6-month duration)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Leadership training program (6-month duration) among female students
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (no training) among female students
Number of subjects: 180
Study: 20331372

Group type: EXPERIMENTAL
Intervention: Electrical stimulation
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (heat, massage, exercises, home program)
Number of subjects: 16
Study: 18317788

Group type: EXPERIMENTAL
Intervention: Oral rifampicin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Submucosal placentrex injection
Number of subjects: 0
Study: 15741048

Group type: EXPERIMENTAL
Intervention: Green tea (GT) - 2 cups containing approximately 250 mg of total catechins
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group - same controlled diet without GT
Number of subjects: 0
Study: 12512987

Group type: EXPERIMENTAL
Intervention: 5% carbamide peroxide bleaching gel + potassium nitrate in a custom tray (Colgate Platinum Gentle Plus)
Number of subjects: 34

Group type: COMPARATOR
Intervention: 6.0% hydrogen peroxide bleaching strips (Crest Whitestrips)
Number of subjects: 34
Study: 11153017

Group type: EXPERIMENTAL
Intervention: ST patients
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: ST patients without atheroma of DTA
Number of subjects: 56
Study: 8783893

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1610984

Group type: EXPERIMENTAL
Intervention: Fish oil (MaxEPA)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Fish oil (MaxEPA) and Placebo (olive oil)
Number of subjects: 16
Study: 6475509

Group type: EXPERIMENTAL
Intervention: Compression screw
Number of subjects: 255

Group type: COMPARATOR
Intervention: Nail plate
Number of subjects: 255
Study: 31273817

Group type: EXPERIMENTAL
Intervention: Progression-free survival
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 0
Study: 28932913

Group type: EXPERIMENTAL
Intervention: Tissue-selecting technique (TST)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Transanal hemorrhoidal dearterialization (THD)
Number of subjects: 80
Study: 24838598

Group type: EXPERIMENTAL
Intervention: R-T-R (reading, self-testing, rereading)
Number of subjects: 0

Group type: COMPARATOR
Intervention: R-R-R (reading three consecutive times)
Number of subjects: 0

Group type: COMPARATOR
Intervention: R-R + N (reading, taking notes, rereading)
Number of subjects: 0
Study: 22905891

Group type: EXPERIMENTAL
Intervention: Tropisetron 5 mg i.v. followed by paracetamol 2 g i.v. 30 min later
Number of subjects: 18

Group type: COMPARATOR
Intervention: Paracetamol 2 g i.v.
Number of subjects: 18
Study: 20852881

Group type: EXPERIMENTAL
Intervention: Heliox (79% helium‐21% oxygen)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Room air (RA)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Heliox (HX)
Number of subjects: 11
Study: 18367379

Group type: EXPERIMENTAL
Intervention: Parenteral nutrition with daily glutamine supplement of 0.35 g/kg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Isocaloric‐isonitrogenous parenteral nutrition (Control)
Number of subjects: 30
Study: 15886045

Group type: EXPERIMENTAL
Intervention: Chronic carpal tunnel syndrome (CTS) subjects
Number of subjects: 11

Group type: COMPARATOR
Intervention: Asymptomatic subjects (control)
Number of subjects: 11
Study: 12633918

Group type: EXPERIMENTAL
Intervention: 16 mg buprenorphine tablets sublingually for 10 days
Number of subjects: 24
Study: 11520747

Group type: EXPERIMENTAL
Intervention: Intraoperative 5-FU
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 9104860

Group type: COMPARATOR
Intervention: Euhydrated with an esophageal temperature (T(es)) of 38.1-38.3 degrees C (control)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Euhydrated and hyperthermic (T(es) of 39.3 degrees C)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Dehydrated and hyperthermic with skin temperature (T(sk)) of 34 degrees C
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Dehydrated with T(es) of 38.1 degrees C and T(sk) of 21 degrees C
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Condition 4 followed by restored blood volume
Number of subjects: 15
Study: 7926425

Group type: COMPARATOR
Intervention: Glyburide
Number of subjects: 25

Group type: COMPARATOR
Intervention: Insulin
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Glyburide and Insulin
Number of subjects: 25
Study: 3440508

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 53

Group type: COMPARATOR
Intervention: Alginate/antacid chewing tablets and metoclopramide
Number of subjects: 53
Study: 2486782

Group type: EXPERIMENTAL
Intervention: 21 days triphasic group (T-21)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 28 days triphasic group (T-28)
Number of subjects: 100

Group type: COMPARATOR
Intervention: 28 days monophasic group (M-28)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Overall tolerance of triphasic preparation (LOGYNON)
Number of subjects: 100
Study: 31868816

Group type: EXPERIMENTAL
Intervention: Increasing training load during a 10 repetition maximum (RM) test
Number of subjects: 29

Group type: COMPARATOR
Intervention: Lower body exercises
Number of subjects: 29

Group type: COMPARATOR
Intervention: Upper body exercises
Number of subjects: 29

Group type: COMPARATOR
Intervention: Machine exercises
Number of subjects: 29

Group type: COMPARATOR
Intervention: Free-weight exercises
Number of subjects: 29
Study: 31952632

Group type: EXPERIMENTAL
Intervention: Xylazine (0.20 mg kg‐1)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.005 mg kg‐1)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 10
Study: 29199999

Group type: COMPARATOR
Intervention: Lavender group (n = 41)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Eucalyptus group (n = 41)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group (n = 41)
Number of subjects: 123
Study: 28991096

Group type: EXPERIMENTAL
Intervention: Computer-assisted cognitive rehabilitation intervention
Number of subjects: 0
Study: 25091954

Group type: EXPERIMENTAL
Intervention: Brilliant blue G (BBG) under air infusion (group 1)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Brilliant blue G (BBG) injected into the vitreous cavity (group 2)
Number of subjects: 63
Study: 23021155

Group type: EXPERIMENTAL
Intervention: Mustard (21 g)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Horseradish (8.3 g)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (no spices)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Ginger (20 g)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Black pepper (1.3 g)
Number of subjects: 22
Study: 22036523

Group type: EXPERIMENTAL
Intervention: Lyprinol(®) 200mg daily for 8 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 19463379

Group type: EXPERIMENTAL
Intervention: Glycoprotein IIb/IIIa antagonist
Number of subjects: 149

Group type: COMPARATOR
Intervention: Conventional group (no GP IIb/IIIa antagonist)
Number of subjects: 149
Study: 16998289

Group type: EXPERIMENTAL
Intervention: Somatostatin
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 98
Study: 15448307

Group type: EXPERIMENTAL
Intervention: Token opportunities (few opportunities)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Closed opportunities (no opportunities)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open opportunities (equal opportunities)
Number of subjects: 0
Study: 11332869

Group type: EXPERIMENTAL
Intervention: alpha‐dihydroergocryptine (10 mg twice daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: propranolol (40 mg twice daily)
Number of subjects: 40
Study: 9522971

Group type: EXPERIMENTAL
Intervention: Oral ofloxacin administration by caregivers
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 91
Study: 7950209

Group type: EXPERIMENTAL
Intervention: Cordyceps sinensis for 7 days
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 3508553

Group type: EXPERIMENTAL
Intervention: Etretinate 25 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Etretinate 50 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Etretinate 75 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Etretinate 100 mg
Number of subjects: 12
Study: 30075813

Group type: EXPERIMENTAL
Intervention: Video-feedback Intervention to promote Positive Parenting and Sensitive Discipline in Foster Care (VIPP-FC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 60
Study: 27067604

Group type: EXPERIMENTAL
Intervention: Didactic group (DG)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Module group (MG)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Comparison between groups
Number of subjects: 33
Study: 23844867

Group type: EXPERIMENTAL
Intervention: Stannous-containing sodium fluoride dentifrice
Number of subjects: 27

Group type: COMPARATOR
Intervention: Negative control dentifrice
Number of subjects: 27
Study: 22947545

Group type: EXPERIMENTAL
Intervention: Whole body vibration (WBV) exercise, performed two days per week for 6 months
Number of subjects: 52

Group type: COMPARATOR
Intervention: No exercise (control group)
Number of subjects: 52
Study: 20884870

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin plus dipyridamole
Number of subjects: 5700
Study: 18432480

Group type: EXPERIMENTAL
Intervention: Self-paced fMRI design
Number of subjects: 0
Study: 16151021

Group type: EXPERIMENTAL
Intervention: Intracoronary transplantation of CPCs
Number of subjects: 26
Study: 12542565

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HRT) with transdermal 17‐beta oestradiol and medroxyprogesterone acetate
Number of subjects: 118

Group type: COMPARATOR
Intervention: Conventional treatment for CHD
Number of subjects: 118

Group type: COMPARATOR
Intervention: Smokers
Number of subjects: 118
Study: 11505388

Group type: EXPERIMENTAL
Intervention: 2 cycles of the same chemotherapy after 6 cycles of induction chemotherapy
Number of subjects: 82

Group type: COMPARATOR
Intervention: (sub)total lymph node irradiation after 6 cycles of induction chemotherapy
Number of subjects: 82
Study: 9248317

Group type: EXPERIMENTAL
Intervention: Formoterol (long-acting beta 2-agonist)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Asthma Quality of Life Questionnaire (AQLQ)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Living with Asthma Quality of Life Questionnaire (LWAQ)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Short Form 36 (SF-36)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Psychological General Well Being (PGWB)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Generic QOL instruments
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: AQLQ vs LWAQ
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: SF-36 vs PGWB and LWAQ
Number of subjects: 110